Clinical trial · Observational
Criteria Associated With Patient Willingness to Participate in Biomedical Research
Criteria Associated With Patient Willingness to Participate in Biomedical Research: a Prospective, Observational Study
NCT03098303CI-TRIAL-00046813PROTOACCEPTcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of this study is to determine the variables associated with patient acceptation or refusal to participate in a clinical research protocol when seen in during a pneumology consultation (excluding oncology and tobaccology).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Consulting in Pneumology Department, But Not for Oncology or Tobacology | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Acceptation or refusal to participate in a biomedical research study
- timeFrame
- Day 0 (cross-sectional study)
- description
- Positive or negative response to the question "If a biomedical research protocole were proposed to you, would you accept to participate?"
Secondary outcomes (1)
- measure
- The PROTOACCEPT questionnaire
- timeFrame
- Day 0 (cross-sectional study)
- description
- The PROTOACCEPT questionnaire (see links below).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * The patient was informed about the study. * The patient is scheduled for a consult in the pneumology department Exclusion Criteria: * The patient is under judicial protection or is an adult under any kind of guardianship * The patient expresses opposition to the study * It is impossible to correctly inform the patient about the study * The patient cannot fluently read French * The patient is pregnant * The patient is breastfeeding * The patient has cancer * The patient is consulting in tabaccology
References
Publications (2)
- RESULTPahus L, Suehs CM, Halimi L, Bourdin A, Chanez P, Jaffuel D, Marciano J, Gamez AS, Vachier I, Molinari N. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials? BMC Med Ethics. 2020 Aug 13;21(1):72. doi: 10.1186/s12910-020-00509-y. PMID 32791969
- RESULTMolinari N, Suehs C, Vachier I, Pahus L, Halimi L, Gamez AS, Chanez P, Bourdin A. Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials. Clin Trials. 2019 Aug;16(4):440-442. doi: 10.1177/1740774519840268. Epub 2019 Mar 29. No abstract available. PMID 30922104